# Current and Evolving Treatments for Myositis

An episode of [ACR on Air](https://invisiblenetwork.ai/podcast/1473160907), 24 Mar 2026, 38 min.

Audio: https://traffic.libsyn.com/secure/acronair/ACR_on_AIR_Strategies_for_Workforce_Retention_mix.mp3?dest-id=1238600

For years, myositis treatment has relied on broad immune suppression with drugs like steroids, methotrexate, and rituximab—but what if we could target the disease more precisely? Inflammatory myopathies are not a single condition, but a group of biologically distinct syndromes with different clinical features and immune pathways. As our understanding evolves, so does the potential for more personalized, targeted therapies. In this episode, we're joined by Dr. Julie J. Paik to discuss how this shift could reshape the future of myositis treatment.

Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them.